Translational Research Cancer Centers Consortium

Expediting Progress in Cancer Immunotherapy
__________________________________________________________________________________

Cynthia L. Sears, MD
Professor of Medicine, Oncology, Molecular
Microbiology and Immunology
Director, Microbiome Program
Bloomberg~Kimmel Institute for Cancer Immunotherapy
Johns Hopkins University School of Medicine
Bloomberg School of Public Health

Dr. Leisha Emens, M.D., Ph.D
Member, Tumor Immunology Research Program
Associate professor of Oncology

Johns Hopkins Medicine 

Copyright Translational Research Cancer Centers Consortium

2018 Annual Meeting Resources

Keynote Speakers

2019 Annual Meeting Chairs

Jonathan Powell, M.D., Ph.D. 
Associate Director, Bloomberg~Kimmel Institute for Cancer Immunotherapy,
Professor of Oncology,

Johns Hopkins Medicine 

SAVE THE DATE

22nd TRCCC Annual Meeting

February 13-15, 2019

Seven Springs, PA


Early Bird Registration deadline: 
January 5, 2019

Abstract Submission deadline: 
January 14, 2019

Resort Reservation deadline: 
January 19, 2019

‚Äč

Organizing Center






Participating Organizations

McMaster University
University of Pennsylvania, Abramson Cancer Center
Barbara Ann Karmanos Cancer Institute
Case Western Reserve University, Case

Columbia University Herbert Irving Comprehensive Cancer Center

Comprehensive Cancer Center

John Hopkins Medicine
University of Michigan Comprehensive Cancer Center
The James, The Ohio State University Comprehensive Cancer Center
Penn State Hershey Cancer Institute 
University of Rochester
Roswell Park Cancer Institute
University of Pittsburgh Cancer Institute

WVU Cancer Institute



Sponsorship Opportunities


Click here for sponsorship Information.


Contact: Stephen T. Haley, Ph.D
SH@immudex.com or (301) 606-9145
if you are interested in sponsoring the TRCCC Annual Meeting.

2019 ANNUAL MEETING

_____________________________________________

Translational Research Cancer Centers Consortium

Ivan M. Borrello, MD
Associate Professor of Oncology
Member, Bloomberg~Kimmel Institute for Cancer Immunotherapy
Director, Cell Therapy and cGMP Biologics Core
Johns Hopkins University School of Medicine